Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist.
It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for …

Conservative management can be considered for the treatment of minimally symptomatic
(ie, no significant pain or breathlessness and no physiological compromise) or …

Malignant pleural effusions are common in patients with cancer. Most malignant pleural
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …

Malignant pleural effusion (MPE) is a common but serious condition that is related with poor
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …

Background Malignant pleural mesothelioma incidence continues to rise, with few available
evidence-based therapeutic options. Results of previous non-randomised studies suggested …

Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …

A total of 21 659 pleural aspirations or drain insertions were conducted in England in
2019/2020 with a combined cost of£ 13.4 million. 1 There are now a variety of different …

Malignant pleural effusion (MPE) is one of the commonest causes of an exudative pleural
effusion, and its incidence is increasing with increasing cancer prevalence and as more …